Keywords
Câncer de Ovário
SARS-CoV-2
Saúde Pública
risco
How to Cite
Abstract
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has introduced a new dimension of risk for cancer patients, especially those with gynecological malignancies such as ovarian cancer. This study aims to evaluate, through an integrative review, the impact of COVID-19 infection on the development and prognosis of ovarian cancer. The research was conducted in August 2024 using the PubMed and LILACS databases with specific descriptors. Inclusion criteria included free full-texts, randomized clinical trials, reviews, and systematic reviews published in the last five years, resulting in the selection of six relevant articles. The results indicate a potential relationship between COVID-19 infection and an increased risk of thromboembolic complications in ovarian cancer patients, although without direct evidence of a causal relationship in increased oncological risk. The discussion of the results emphasizes the need for reinforced protective measures and adjustments in treatment protocols for cancer patients during pandemics. The conclusion highlights that, although a direct causal relationship between COVID-19 infection and increased ovarian cancer risk has not been identified, the pandemic has exacerbated existing challenges for cancer patients, underscoring the need for further research to fully understand these complex interactions.
References
ISACHENKO, Vladimir et al. Alta Crioresistência do Vírus SARS-CoV-2: Risco Aumentado de Re-contaminação no Transplante de Tecido Ovariano Criopreservado após a Pandemia de COVID-19. Cryobiology, [s.l.], v. 103, p. 1–6, set. 2021. Disponível em: https://doi.org/10.1016/j.cryobiol.2021.09.009. Acesso em: 17 ago. 2024.
STEFAN, Alexandra et al. Increased risk for thromboembolic events from combination of a gynecologic malignancy with severe acute respiratory syndrome coronavirus 2 infection: a case report. Journal of Medical Case Reports, [s.l.], v. 16, p. 119, abr. 2022. Disponível em: https://doi.org/10.1186/s13256-022-03340-8. Acesso em: 17 ago. 2024.
LI, Zengbin et al. Cancers and COVID-19 Risk: A Mendelian Randomization Study. Cancers, [s.l.], v. 14, n. 9, art. 2086, 2022. Disponível em: https://doi.org/10.3390/cancers14092086. Acesso em: 18 ago. 2024.
SCHWAB, Roxana et al. Patients’ expectations of preventive measures of medical institutions during the SARS-CoV-2 pandemic in Germany in women with an increased risk of breast and ovarian cancer: a cross-sectional, web-based survey. BMJ Open, [s.l.], v. 12, p. e060038, 2022. Disponível em: 10.1136/bmjopen-2021-060038. Acesso em: 19 ago. 2024.
SCHWAB, Roxana et al. Resilience as a Source of Easement to Health-Related Worries in Women at Increased Risk for Breast or Ovarian Cancer During the COVID-19 Pandemic. International Journal of General Medicine Dovepress, [s.l.], v. 15, p. 7039–7052, 2022. Disponível em: https://doi.org/10.2147/IJGM.S373191. Acesso em: 19 ago. 2024.
MATSUO, K; MANDELBAUM, RS; VALLEJO, A; KLAR, M; ROMAN, LD; WRIGHT, JD. Assessment of gender-specific COVID-19 case fatality risk per malignant neoplasm type. JAMA Oncology, [s.l.], 2023. Disponível em: doi:10.1001/jamaoncol.2023.0768. Acesso em: 19 ago. 2024.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Mauricio Marlon Mota de Oliveira , Stefan Gabriel Gonçalves Martiniano , Iramaia Fernanda Kataoka, Lucas Roberto Pereira Casarotto , Maria Eduarda Guisoni Elias, Adrielly Nunes dos Santos , Marx Felipe Paixão Dornelas, Daniela Ferreira Marques , Taís Rocha Morais de Santiago , Cicero Decio Soares Grangeiro